You are here

Innovations

Innovations

Technology and Techniques in Cardiothoracic and Vascular Surgery

eISSN: 15590879 | ISSN: 15569845 Frequency: Bi-monthly
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery is the first journal whose main mission is to disseminate information specifically about advances in technology and techniques that lead to less invasive treatment of cardiothoracic and vascular disease. It delivers cutting edge original research, reviews, essays, case reports, and editorials from the pioneers and experts in the field of minimally invasive cardiothoracic and vascular disease, including biomedical engineers. Also included are papers presented at the annual ISMICS meeting.

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, the official journal of the International Society for Minimally Invasive Cardiothoracic Surgery, aims to disseminate information about advances in technology and techniques that might lead to less invasive treatment of cardiothoracic and vascular disease than measures regularly used.

Editor in Chief
Niv Ad, MD Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD
Managing Editor
Sari D. Holmes, PhD Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD
Associate Editors
Tohru Asai, MD, PhD Otsu, Japan
Edward M. Bender, MD Corvallis, Oregon, USA
Donna E. Maziak, MD Ottawa, ON, Canada
Noedir A. G. Stolf, MD, PhD Sao Paulo, Brazil
Piotr Suwalski, MD, PhD Warsaw, Poland
Grayson H. Wheatley, III, MD Nashville, Tennessee, USA
Bobby Yanagawa, MD Toronto, Canada
Editorial Board
Husam H. Balkhy, MD Chicago, Illinois, USA
Dan Bethencort, MD Long Beach, CA, USA
Nikolaos Bonaros, MD Innsbruck, Austria
Johannes O. Bonatti, MD Abu Dhabi, United Arab Emirates
Antonio M. Calafiore, MD Riyadh, Saudi Arabia
Suchart Chaiyaroj, MD  
Davy C. H. Cheng, MD London, ON, Canada
Robert W. Emery, Jr., MD Tucson, Arizona, USA
Changqing Gao, MD Beijing, China
Mattia Glauber, MD Milano, Italy
Donald D. Glower, MD Durham, North Carolina, USA
Paul F. Grundeman, MD, PhD Utrecht, The Netherlands
Vassilios Gulielmos, MD Thessaloniki, Greece
Michael E. Halkos, MD Atlanta, Georgia, USA
Marjan Jahangiri, MD London, UK
Vivek S. Jawali, MD Bangalore, India
Bob B. Kiaii, MD London, ON, Canada
Young Tae Kim, MD, PhD Seoul, Korea
Jennifer S. Lawton, MD Baltimore, Maryland, USA
Eric J. Lehr, MD, PhD Seattle, Washington, USA
Virginia R. Litle, MD Boston, Massachusetts, USA
Saqib Masroor, MD Miami, Florida, USA
Spencer J. Melby, MD St. Louis, Missouri, USA
Xu Meng, MD Beijing, China
Simon C. Moten, MD Melbourne, Australia
Calvin S. H. Ng, MD Hong Kong, China
Takashi Nitta, MD, PhD Tokyo, Japan
Nirav C. Patel, MD New York, New York, USA
John R. Pepper, FRCS London, United Kingdom
Hermann Reichenspurner, MD, PhD Hamburg, Germany
Scott I. Reznik, MD Dallas, Texas, USA
Harold G. Roberts, MD Aventura, Florida, USA
Evelio Rodriguez, MD Nashville, Tennessee, USA
Ricardo Sales dos Santos, MD Sao Paulo, Brazil
Sahin Senay, MD Istanbul, Turkey
John A. Spratt, MD Charleston, South Carolina, USA
Vinod H. Thourani, MD Washington, DC, USA
Gregory D. Trachiotis, MD  
Huishan Wang, MD  
Go Watanabe, MD, PhD Tokyo, Japan
Timo Weimar, MD Stuttgart, Germany
Benny Weksler, MD Memphis, Tennessee, USA
Gerhard Wimmer-Greinecker, MD, PhD Bad Bevensen, Germany
  • Clarivate Analytics: Emerging Sources Citation Index (ESCI)
  • PubMed: MEDLINE
  • Scopus
  • Innovations:Technology and Techniques in Cardiothoracic and Vascular Surgery accepts manuscript submissions through a submission service on another website.

    Innovations:Technology and Techniques in Cardiothoracic and Vascular Surgery has specific instructions and guidelines for submitting articles. Those instructions and guidelines are readily available on the submission service site. Please read and review them carefully. Articles that are not submitted in accordance with our instructions and guidelines are more likely to be rejected.

    For further information, please go to: https://journals.lww.com/innovjournal/_layouts/15/1033/oaks.journals/informationforauthors.aspx

     

    1. Types of articles considered

    2. Editorial policies

    2.1 Peer review policy

    2.2 Authorship

    2.3 Acknowledgements

    2.4 Funding

    2.5 Declaration of conflicting interests

    2.6 Research ethics

    2.7 Patient consent

    2.8 Randomized controlled trials

    3. Publishing policies

    3.1 Contributor’s publishing agreement

    3.2 Open access and author archiving

    3.3 Permissions

    4. Preparing your manuscript

    4.1 File types

    4.2 Artwork, figures and other graphics

    4.3 Submitting additional material

    4.4 Journal layout

    4.5 Reference style

    4.6 English language editing services

    5. Submitting your manuscript

    5.1 Title, keywords and abstracts

    5.2 Corresponding author contact details

    6. On acceptance and publication

    6.1 SAGE Production

    6.2 Access to your published article

    6.3 Online First publication

    7. Further information

    Back to top

    Please read the guidelines below then visit the Journal’s submission site https://www.editorialmanager.com/innov/default.aspx to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    1. Types of articles considered

    The editor invites submission of 1) original articles, based on observation or experimentation that add new knowledge to the field of cardiothoracic and vascular surgery, especially if it might lead to less invasive treatment, 2) pictorial essays, that primarily utilize images to review a specific subject, 3) case reports, describing a unique aspect of cardiothoracic or vascular surgery not previously described in the literature, 4) review articles, solicited by the editor or guest editor as part of a symposium or as a state-of-the-art review, which codify existing knowledge or throw light on the present and future roles of minimally invasive cardiothoracic and vascular surgery, and 5) editorials reflecting the opinions of authorities in the field. The Journal will publish papers in the areas of cardiothoracic and vascular surgery, medicine, physiology, pathology, and imaging technology.

     

    2. Editorial policies

    2.1 Peer review policy

    Three independent peer reviwers are assigned by an associate editor. Except for case reports where there will be two peer reviewers.  The Editor is responsible for all final decisions regarding acceptance or rejection, recommendations for revision, and final editing. Manuscripts will be evaluated according to various criteria, including an ethics check. The review process is typically 16 days. Innovations wants to maintain a fast review process.

    All submitted articles are "double-blinded" to ensure an unbiased review. Reviewers will not have access to author names or affiliations. Authors will not have access to reviewer names or affiliations.

    2.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

    The list of authors should include all those who can legitimately claim authorship. This is all those who:

    made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data,

    drafted the article or revised it critically for important intellectual content,

    approved the version to be published.

    Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

    When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section.

    Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines:

    http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html

    2.3 Acknowledgements

    Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

    All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgements’ section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.

    2.4 Funding

    To comply with the guidance for Research Funders, Authors and Publishers issued by the Research Information Network (RIN), Innovations additionally requires all Authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit Funding Acknowledgements on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding or state in your acknowledgments that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

    2.5 Declaration of conflicting interests

    It is the policy of Innovations to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

    Please include any declaration at the end of your manuscript after any acknowledgements and prior to the references, under a heading ‘Conflict of interests’. If no declaration is made the following will be printed under this heading in your article: ‘None declared’. Alternatively, you may wish to state that ‘The Author(s) declare(s) that there is no conflict of interest’.

    When making a declaration the disclosure information must be specific and include any financial relationship that all authors of the article has with any sponsoring organization and the for-profit interests the organization represents, and with any for-profit product discussed or implied in the text of the article.

    Any commercial or financial involvements that might represent an appearance of a conflict of interest need to be additionally disclosed in the covering letter accompanying your article to assist the Editor in evaluating whether sufficient disclosure has been made within the Declaration of Conflicting Interests provided in the article.

    For more information please visit the SAGE Journal Author Gateway

    2.6 Research ethics

    All papers reporting animal and/or human studies must include whether written consent was obtained from the local Ethics Committee or Institutional Review Board. Please ensure that you have provided the full name and institution of the review committee and an Ethics Committee reference number.

    We accept manuscripts that report human and/or animal studies for publication only if it is made clear that investigations were carried out to a high ethical standard. Studies in humans which might be interpreted as experimental (e.g. controlled trials) should conform to the Declaration of Helsinki and typescripts must include a statement that the research protocol was approved by the appropriate ethical committee. In line with the Declaration of Helsinki 1975, revised Hong Kong 1989, we encourage authors to register their clinical trials (at http://clinicaltrials.gov or other suitable databases identified by the ICMJE on their website). If your trial has been registered, please state this on the Title Page. When reporting experiments on animals, indicate on the Title Page which guideline/law on the care and use of laboratory animals was followed.

    2.7 Patient consent

    Authors are required to ensure the following guidelines are followed, as per the IJMCE’s recommendations. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.

    Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the submitted article.

    2.8 Randomized controlled trials

    All randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart. Please refer to the CONSORT statement website at http://www.consort-statement.org for more information.

    Back to top

    3. Publishing Policies

    3.1 Contributor’s publishing agreement

    Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society.

    For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.

    Innovations and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; banning the author from publication in the journal or all SAGE journals, or appropriate legal action.

    3.2 Open access and author archiving

    For more information on the open access options for Innovations, funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.

    3.3 Permissions

    Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.

    Back to top

    4. Preparing your manuscript

    4.1 File types

    Only electronic files conforming to the journal's guidelines will be accepted. Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. LaTeX files are also accepted. The text should be double-spaced throughout and with a minimum of 3cm for left and right hand margins and 5cm at head and foot. Text should be standard 10 or 12 point.

    4.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines

    Figures supplied in colour will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the costs from SAGE after receipt of your accepted article.

    4.3 Submitting additional material

    This journal is able to host additional materials online (e.g. datasets, AV files) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to SAGE’s Guidelines for Authors on Supplemental Files.

    4.4 Journal layout

    4.5 Reference Style

    Innovation adheres to the SAGE reference style. Click here to review the guidelines on SAGE Vancouver to ensure your manuscript conforms to this reference style.

    Up to three authors may be listed. If more, then list the first three authors and represent the rest by et al.

    4.6 English language editing services

    Authors who would like to refine the use of English in their manuscripts might consider using the services of a professional English-language editing company. Visit SAGE Language Services on our Journal Author Gateway for further information.

    5. Submitting your manuscript

    Innovations is hosted on Editorial Manager. Manuscripts may be submitted at http://www.editorialmanager.com/innov/default.aspx.

    5.1 Title, keywords and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting SAGE’s Journal Author Gateway Guidelines on How to Help Readers Find Your Article Online.

    5.2 Corresponding author contact details

    Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

    Back to top

    6. On acceptance and publication

    6.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly.

    6.2 Access to your published article

    SAGE provides authors with online access to their final article.

    6.3 Online First publication

    Online First allows final revision articles (completed articles in queue for assignment to an upcoming issue) to be published online prior to their inclusion in a final journal issue which significantly reduces the lead time between submission and publication. For more information please visit our Online First Fact Sheet

    7. Further information

    Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Innovation editorial office as follows:

     

    Individual Subscription, Combined (Print & E-access)


    Institutional Subscription, E-access


    Institutional Subscription, Print Only


    Institutional Subscription, Combined (Print & E-access)


    Individual, Single Print Issue


    Institutional, Single Print Issue